Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CAD Impact On Clinical Decisions Warrants Guidance Document – Philips Rep

This article was originally published in The Gray Sheet

Executive Summary

The relationship between the performance of computer-aided detection (CAD) technologies and actual clinical outcomes merits clarification from FDA and CMS, according to Philips Nuclear Medicine Chief Medical Officer David Rollo
Advertisement

Related Content

FFDM Will Ease Access, Enhance Performance Via Telemedicine – CEO Nields
Pitching CT Lung Cancer Screening To Consumers Inadvisable – JAMA Study
Spiral CT Will Be Compared With Chest X-Ray In NCI Lung Screening Trial
Spiral CT Will Be Compared With Chest X-Ray In NCI Lung Screening Trial
Advertisement
UsernamePublicRestriction

Register

MT017894

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel